1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. Monocarboxylate Transporter
  4. MCT4 Isoform

MCT4

Monocarboxylate transporter 4 (MCT4) also known as solute carrier family 16 member 3 (SLC16A3). MCT4 acts as an H+/lactate exporter in highly glycolytic tissues. In fact, MCT4 was first identified as a key component of lactate efflux in highly glycolytic white fiber myocytes, and was later demonstrated to show a high affinity for lactate over other monocarboxylates, as referenced by its comparatively lower Km for lactate. Furthermore, MCT4 has been shown to be overexpressed in diverse types of neoplasia, among malignant gliomas. Mechanistically, MCT4 is upregulated under hypoxia via binding of HIF-1α to two hypoxic response elements (HRE) within the SLC16A3 promoter. This process enables tumor cells, including those within the core of the heterogeneous tumor mass to survive, despite being at a distance from blood vessels that supply their metabolic needs.

MCT4 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-132301
    MSC-4381
    Inhibitor 98.11%
    MSC-4381 (MCT4-IN-1) is an orally active and selective monocarboxylate transporter 4 (MCT4/SLC16A3) inhibitor with an IC50 of 77 nM and a Ki of 11 nM.
  • HY-148517
    AZD0095
    Inhibitor 99.59%
    AZD0095 is a selective and orally active MCT4 inhibitor (IC50: 1.3 nM).